-
Lupin launches generic HIV drug
BALTIMORE — Lupin has launched a generic drug for treating HIV, following its victory in a patent-infringement suit in federal court, the Indian drug maker said Wednesday.
Lupin's U.S. subsidiary launched its generic version of ViiV Healthcare's Trizivir (abacavir sulfate; lamivudine; zidovudine) tablets in the 300-mg/150-mg/300-mg strength. The launch follows a ruling by the U.S. District Court for the District of Delaware that the drug did not infringe on Viiv's patent.
-
NCPA: CMS policy change — pharmacies to affirmatively obtain consent from a beneficiary prior to shipping
ALEXANDRIA, Va. — Nearly 1,200 seniors have complained to Medicare this year about a litany of problems with mail-order pharmacies, including shipping unneeded medication and going without medication due to delayed shipments, the National Community Pharmacists Association noted Tuesday citing documentation recently released by the U.S. Centers for Medicare & Medicaid Services.